R. Sutmuller

发表

In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity

Carl G. Figdor, C. Figdor, G. Adema, 2004, Cancer Research.

Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

T. Schumacher, R. Offringa, C. Melief, 2001, The Journal of experimental medicine.

Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cells.

S. H. van der Burg, R. Offringa, C. Melief, 2002, Cancer research.

IL-10 and Regulatory T Cells through Induction Candida albicans against Toll-Like Receptor 2 Suppresses Immunity

M. Netea, T. Hartung, J. Meer, 2004 .

Uveal Melanoma Targeting gp 100 Adoptive T Cell Immunotherapy of Human Rienk Offringa

C. Melief, J. Tine, M. Jager, 2000 .

Adoptive T Cell Immunotherapy of Human Uveal Melanoma Targeting gp1001

R. Offringa, C. Melief, C. Melief, 2000, The Journal of Immunology.

Toll-Like Receptor 2 Suppresses Immunity

M. Netea, J. Meer, G. Adema, 2004 .

Multifaceted effects of synthetic TLR2 ligand and Legionella pneumophilia on Treg-mediated suppression of T cell activation

G. Adema, S. Nierkens, J. Bolscher, 2011, BMC Immunology.

Mild impairment of motor nerve repair in mice lacking PTP-BL tyrosine phosphatase activity.

F. Oerlemans, B. Wieringa, G. Adema, 2004, Physiological genomics.

CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis.

R. Toes, R. Sutmuller, M. E. Morgan, 2004, Human immunology.

CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.

R. Offringa, C. Melief, R. Toes, 2003, Arthritis and rheumatism.

Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate‐pulsed dendritic cells in a murine glioma model

G. Adema, S. Nierkens, O. Grauer, 2007, International journal of cancer.

Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens.

R. Offringa, S. Rosenberg, K. Irvine, 1999, Cancer research.

Highly Efficient Transduction of Human Monocyte-Derived Dendritic Cells with Subgroup B Fiber-Modified Adenovirus Vectors Enhances Transgene-Encoded Antigen Presentation to Cytotoxic T Cells1

R. Offringa, C. Melief, M. Havenga, 2001, The Journal of Immunology.

Antigen Presentation to Cytotoxic T Cells Vectors Enhances Transgene-Encoded Subgroup B Fiber-Modified Adenovirus Monocyte-Derived Dendritic Cells with Highly Efficient Transduction of Human

M. Havenga, A. Lemckert, A. Bout, 2001 .

Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice

W. Hinrichs, H. Frijlink, E. van Gulck, 2018, PloS one.

From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias

M. Netea, G. Adema, B. Kullberg, 2005, Antimicrobial Agents and Chemotherapy.

Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells

M. Netea, T. Hartung, G. Adema, 2004, The Journal of Immunology.

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo

L. Boon, P. Wesseling, G. Adema, 2007, International journal of cancer.

Rejection of Intraocular Tumors by CD4+ T Cells Without Induction of Phthisis1

C. Melief, J. Medema, J. Laman, 2001, The Journal of Immunology.

Humanized Mice Recapitulate Key Features of HIV-1 Infection: A Novel Concept Using Long-Acting Anti-Retroviral Drugs for Treating HIV-1

E. Schlaepfer, R. Speck, D. Boden, 2012, PloS one.

Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine

R. Offringa, C. Melief, J. Allison, 2001, The Journal of experimental medicine.

Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.

C. Figdor, G. Adema, S. Nierkens, 2006, Cancer research.

Toll-like receptor 2 controls expansion and function of regulatory T cells.

L. Joosten, M. Netea, S. Akira, 2006, The Journal of clinical investigation.

Revival of the regulatory T cell: new targets for drug development.

R. Offringa, C. Melief, R. Sutmuller, 2004, Drug discovery today.

TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas1

G. Adema, S. Nierkens, O. Grauer, 2008, The Journal of Immunology.

Regulatory T cells and toll-like receptors: regulating the regulators

G. Adema, R. Sutmuller, Gosse J Adema, 2007, Annals of the rheumatic diseases.

Toll-like receptors on regulatory T cells: expanding immune regulation.

M. Netea, G. Adema, O. Grauer, 2006, Trends in immunology.

Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients

C. Figdor, C. Punt, G. Adema, 2010, Clinical Cancer Research.

CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity

A. Akarca, T. Marafioti, S. Quezada, 2020, Nature Cancer.

Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity

C. Figdor, G. Adema, O. Boerman, 2006, British Journal of Cancer.

Clinical Cancer esearch cer Therapy : Clinical dritic Cell Vaccination in Combination with Anti-CD 25 oclonal Antibody Treatment : A Phase I / II Study in R astatic Melanoma Patients

C. Punt, L. Hilbrands, I. Klasen, 2010 .

In vivo colocalization of antigen and CpG [corrected] within dendritic cells is associated with the efficacy of cancer immunotherapy.

C. Figdor, G. Adema, S. Nierkens, 2008, Cancer research.

Toll-Like Receptor / T-Helper Bias From the Th 1 / Th 2 Paradigm towards a

M. Netea, J. Meer, G. Adema, 2005 .

Functional analysis of the T-cell-restricted protein tyrosine kinase Txk.

R. Sutmuller, J. Ellis, M. Sims, 1998, The Biochemical journal.